Nectero Medical
About:
Nectero Medical develops a novel treatment to stabilize growth and prevent rupture of mid-sized abdominal aortic aneurysms.
Website: https://necteromedical.com
Top Investors: Alumni Ventures, Norwest Venture Partners, Boston Scientific, KOFA Healthcare, Aphelion Capital
Description:
Nectero Medical develops a novel treatment to stabilize growth and prevent rupture of mid-sized abdominal aortic aneurysms. The company was founded in 2017 and is headquartered in Dover, Delaware, United States.
Total Funding Amount:
$116M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Tempe, Arizona, United States
Founded Date:
2017-01-01
Contact Email:
info(AT)necteromed.com
Founders:
Number of Employees:
11-50
Last Funding Date:
2024-04-11
IPO Status:
Private
Industries:
© 2025 bioDAO.ai